Tags

Type your tag names separated by a space and hit enter

[Scleroderma renal crisis].
Reumatizam. 2010; 57(2):109-11.R

Abstract

Systemic sclerosis (SSc) is a multisystem disease whose clinical manifestations result from inflammation, vascular injury and obliteration, and cutaneous and visceral fibrosis. Scleroderma renal crisis (SRC) occurs in 5% of patients with particullary diffuse form of SSc. It is characterized by malignant hypertension and oligo/ anuric acute renal failure. SRC was once a uniformly fatal complication of SSc. The prognosis of SRC has significantly improved with the introduction of angiotensin-converting enzyme inhibitors (ACEi) as treatment. The treatment of SRC relies on tight control of blood pressure and aggressive treatment with ACEi, if needed in combination with other types of antihypertensive drugs.

Authors+Show Affiliations

Zavod za klinicku imunologiju i reumatologiju, 10000 Zagreb. jmorovic@kbd.hrNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

hrv

PubMed ID

21875014

Citation

Morović-Vergles, Jadranka, et al. "[Scleroderma Renal Crisis]." Reumatizam, vol. 57, no. 2, 2010, pp. 109-11.
Morović-Vergles J, Culo MI, Kaliterna DM. [Scleroderma renal crisis]. Reumatizam. 2010;57(2):109-11.
Morović-Vergles, J., Culo, M. I., & Kaliterna, D. M. (2010). [Scleroderma renal crisis]. Reumatizam, 57(2), 109-11.
Morović-Vergles J, Culo MI, Kaliterna DM. [Scleroderma Renal Crisis]. Reumatizam. 2010;57(2):109-11. PubMed PMID: 21875014.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Scleroderma renal crisis]. AU - Morović-Vergles,Jadranka, AU - Culo,Melanie Ivana, AU - Kaliterna,Dusanka Martinović, PY - 2011/8/31/entrez PY - 2010/1/1/pubmed PY - 2011/11/1/medline SP - 109 EP - 11 JF - Reumatizam JO - Reumatizam VL - 57 IS - 2 N2 - Systemic sclerosis (SSc) is a multisystem disease whose clinical manifestations result from inflammation, vascular injury and obliteration, and cutaneous and visceral fibrosis. Scleroderma renal crisis (SRC) occurs in 5% of patients with particullary diffuse form of SSc. It is characterized by malignant hypertension and oligo/ anuric acute renal failure. SRC was once a uniformly fatal complication of SSc. The prognosis of SRC has significantly improved with the introduction of angiotensin-converting enzyme inhibitors (ACEi) as treatment. The treatment of SRC relies on tight control of blood pressure and aggressive treatment with ACEi, if needed in combination with other types of antihypertensive drugs. SN - 0374-1338 UR - https://www.unboundmedicine.com/medline/citation/21875014/[Scleroderma_renal_crisis]_ L2 - http://www.diseaseinfosearch.org/result/6459 DB - PRIME DP - Unbound Medicine ER -